CN106259079A - 一种河蟹的生态养殖方法 - Google Patents
一种河蟹的生态养殖方法 Download PDFInfo
- Publication number
- CN106259079A CN106259079A CN201610645173.8A CN201610645173A CN106259079A CN 106259079 A CN106259079 A CN 106259079A CN 201610645173 A CN201610645173 A CN 201610645173A CN 106259079 A CN106259079 A CN 106259079A
- Authority
- CN
- China
- Prior art keywords
- water
- chinese medicine
- bait
- crab
- pond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012364 cultivation method Methods 0.000 title claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 143
- 239000003814 drug Substances 0.000 claims abstract description 79
- 241000371997 Eriocheir sinensis Species 0.000 claims abstract description 50
- 239000000654 additive Substances 0.000 claims abstract description 43
- 230000000996 additive effect Effects 0.000 claims abstract description 43
- 230000000366 juvenile effect Effects 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 13
- 230000008569 process Effects 0.000 claims abstract description 8
- 230000008859 change Effects 0.000 claims abstract description 7
- 235000011399 aloe vera Nutrition 0.000 claims description 38
- 241001116389 Aloe Species 0.000 claims description 37
- 238000012258 culturing Methods 0.000 claims description 35
- RAFZYSUICBQABU-HMMYKYKNSA-N Phytal Chemical compound CC(C)CCCC(C)CCCC(C)CCC\C(C)=C\C=O RAFZYSUICBQABU-HMMYKYKNSA-N 0.000 claims description 30
- RAFZYSUICBQABU-QYLFUYDXSA-N Phytal Natural products CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C/C=O RAFZYSUICBQABU-QYLFUYDXSA-N 0.000 claims description 30
- UZVHFVZFNXBMQJ-UHFFFAOYSA-N butalbital Chemical compound CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O UZVHFVZFNXBMQJ-UHFFFAOYSA-N 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 30
- RAFZYSUICBQABU-UHFFFAOYSA-N phytenal Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)=CC=O RAFZYSUICBQABU-UHFFFAOYSA-N 0.000 claims description 30
- 241000628997 Flos Species 0.000 claims description 25
- 239000002994 raw material Substances 0.000 claims description 25
- 239000011812 mixed powder Substances 0.000 claims description 22
- 230000003203 everyday effect Effects 0.000 claims description 21
- 235000013372 meat Nutrition 0.000 claims description 18
- 238000004659 sterilization and disinfection Methods 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 17
- 239000004575 stone Substances 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 13
- 239000010231 banlangen Substances 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 235000013360 fish flour Nutrition 0.000 claims description 10
- 239000011888 foil Substances 0.000 claims description 10
- 239000003415 peat Substances 0.000 claims description 10
- 239000004033 plastic Substances 0.000 claims description 10
- 239000002689 soil Substances 0.000 claims description 10
- 244000025254 Cannabis sativa Species 0.000 claims description 9
- 241000238557 Decapoda Species 0.000 claims description 7
- 102000002322 Egg Proteins Human genes 0.000 claims description 7
- 108010000912 Egg Proteins Proteins 0.000 claims description 7
- 239000009526 Fructus Akebiae Substances 0.000 claims description 7
- 240000002853 Nelumbo nucifera Species 0.000 claims description 7
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 7
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 241000287828 Gallus gallus Species 0.000 claims description 6
- 235000013601 eggs Nutrition 0.000 claims description 6
- 239000012286 potassium permanganate Substances 0.000 claims description 6
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 6
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 5
- 244000105624 Arachis hypogaea Species 0.000 claims description 5
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 5
- 235000018262 Arachis monticola Nutrition 0.000 claims description 5
- 229920002261 Corn starch Polymers 0.000 claims description 5
- 241000195493 Cryptophyta Species 0.000 claims description 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 5
- 241000382353 Pupa Species 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 238000005273 aeration Methods 0.000 claims description 5
- 230000037396 body weight Effects 0.000 claims description 5
- 239000008120 corn starch Substances 0.000 claims description 5
- 210000003278 egg shell Anatomy 0.000 claims description 5
- 150000002333 glycines Chemical class 0.000 claims description 5
- 235000012054 meals Nutrition 0.000 claims description 5
- 230000000474 nursing effect Effects 0.000 claims description 5
- 235000020232 peanut Nutrition 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 244000052355 Hydrilla verticillata Species 0.000 claims 1
- 241000257673 Strobilanthes cusia Species 0.000 claims 1
- 238000009738 saturating Methods 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 11
- 230000004083 survival effect Effects 0.000 abstract description 8
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 244000052616 bacterial pathogen Species 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 5
- 230000000840 anti-viral effect Effects 0.000 abstract description 4
- 230000036737 immune function Effects 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 4
- 230000000843 anti-fungal effect Effects 0.000 abstract description 3
- 229940121375 antifungal agent Drugs 0.000 abstract description 3
- 230000000749 insecticidal effect Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 38
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 24
- 210000002216 heart Anatomy 0.000 description 19
- 239000000796 flavoring agent Substances 0.000 description 17
- 235000019634 flavors Nutrition 0.000 description 17
- 210000002700 urine Anatomy 0.000 description 16
- 230000006870 function Effects 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 11
- 244000045947 parasite Species 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 8
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- REZQBEBOWJAQKS-UHFFFAOYSA-N triacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO REZQBEBOWJAQKS-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 239000006286 aqueous extract Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000010253 intravenous injection Methods 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- XQCGNURMLWFQJR-ZNDDOCHDSA-N Cymarin Chemical compound O1[C@H](C)[C@@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)CC[C@@H]3[C@@]2(C=O)CC1 XQCGNURMLWFQJR-ZNDDOCHDSA-N 0.000 description 4
- XQCGNURMLWFQJR-UESCRGIISA-N Cymarin Natural products O=C[C@@]12[C@@](O)(C[C@@H](O[C@H]3O[C@@H](C)[C@@H](O)[C@@H](OC)C3)CC1)CC[C@H]1[C@]3(O)[C@@](C)([C@H](C4=CC(=O)OC4)CC3)CC[C@H]21 XQCGNURMLWFQJR-UESCRGIISA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000498251 Hydrilla Species 0.000 description 4
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229960003083 cymarin Drugs 0.000 description 4
- 229930182486 flavonoid glycoside Natural products 0.000 description 4
- 150000007955 flavonoid glycosides Chemical class 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 235000005875 quercetin Nutrition 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- FHIREUBIEIPPMC-UHFFFAOYSA-N K-Strophanthin-beta Natural products O1C(C)C(OC2C(C(O)C(O)C(CO)O2)O)C(OC)CC1OC(CC1(O)CCC2C3(O)CC4)CCC1(C=O)C2CCC3(C)C4C1=CC(=O)OC1 FHIREUBIEIPPMC-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 3
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 3
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 3
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- CTNPHHZPAJYPFO-PDXBGNJTSA-N (3s,5s,8r,9s,10s,13r,14s,17r)-3-[(2r,4s,5r,6r)-5-[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,14-dihydroxy-13-methyl-17-(5-oxo-2h-furan Chemical compound C1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C=O)CC[C@@H](C[C@@]5(O)CC[C@H]4[C@@]3(O)CC2)O[C@H]2C[C@@H]([C@@H]([C@@H](C)O2)O[C@@H]2[C@H]([C@H](O)[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](CO)O2)O)OC)=CC(=O)OC1 CTNPHHZPAJYPFO-PDXBGNJTSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 206010002953 Aphonia Diseases 0.000 description 2
- 241000722949 Apocynum Species 0.000 description 2
- 241000185686 Apocynum venetum Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N Indigo Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- HOEVRHHMDJKUMZ-UHFFFAOYSA-N Isofraxidin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2OC HOEVRHHMDJKUMZ-UHFFFAOYSA-N 0.000 description 2
- ANCHXLMTFNOVDK-UHFFFAOYSA-N Isofraxidin Natural products COC1=C(O)C(OC)=CC2=C1OC=CC2=O ANCHXLMTFNOVDK-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000507 anthelmentic effect Effects 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 229930182482 anthraquinone glycoside Natural products 0.000 description 2
- 229940098421 anthraquinone glycoside Drugs 0.000 description 2
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 2
- 230000003260 anti-sepsis Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002008 hemorrhagic effect Effects 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- GBRZTUJCDFSIHM-KRWDZBQOSA-N licoricidin Chemical compound C1([C@@H]2COC=3C=C(O)C(CC=C(C)C)=C(C=3C2)OC)=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-KRWDZBQOSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 208000020442 loss of weight Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- ODJLBQGVINUMMR-HZXDTFASSA-N strophanthidin Chemical compound C1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@@]5(O)CC4)C=O)CC[C@@]32C)=CC(=O)OC1 ODJLBQGVINUMMR-HZXDTFASSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- KMEHEQFDWWYZIO-UHFFFAOYSA-N triacontyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC KMEHEQFDWWYZIO-UHFFFAOYSA-N 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- DLHXRDUXNVEIEY-UHFFFAOYSA-N 7-Methylcoumarin Chemical compound C1=CC(=O)OC2=CC(C)=CC=C21 DLHXRDUXNVEIEY-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000722948 Apocynum cannabinum Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 206010048610 Cardiotoxicity Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000601170 Clematis lasiantha Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241001633942 Dais Species 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010015967 Eye swelling Diseases 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- ZNDMLUUNNNHNKC-UHFFFAOYSA-N G-strophanthidin Natural products CC12CCC(C3(CCC(O)CC3(O)CC3)CO)C3C1(O)CCC2C1=CC(=O)OC1 ZNDMLUUNNNHNKC-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- GFJNBLOMWYSKSS-UHFFFAOYSA-N Isoglycyrol Natural products COc1c2CCC(C)(C)Oc2cc3OC(=O)c4c(oc5c(O)cccc45)c13 GFJNBLOMWYSKSS-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- MVAUGMLUJKTORM-UHFFFAOYSA-N Licoricidin Natural products COc1cc2OCC(Cc2cc1CC=C(C)C)c3ccc(O)c(CC=C(C)C)c3O MVAUGMLUJKTORM-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 229920001231 Polysaccharide peptide Polymers 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- ODJLBQGVINUMMR-UHFFFAOYSA-N Strophanthidin Natural products CC12CCC(C3(CCC(O)CC3(O)CC3)C=O)C3C1(O)CCC2C1=CC(=O)OC1 ODJLBQGVINUMMR-UHFFFAOYSA-N 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 206010043087 Tachyphylaxis Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- BWXDHBQGBNPJMN-VBHWJLTNSA-N [(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] hexadecanoate Chemical compound C([C@@]1(C)CC[C@H]([C@@H]1[C@H]1CC[C@H]23)C(C)=C)C[C@@]1(C)[C@]3(C)CC[C@@H]1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC)C1(C)C BWXDHBQGBNPJMN-VBHWJLTNSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 231100000259 cardiotoxicity Toxicity 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- UNKAUFQSKMCCBV-UHFFFAOYSA-N hexadecyl hexadecanoate 2-tetradecyloctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCC(C(O)=O)CCCCCCCCCCCCCC UNKAUFQSKMCCBV-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- CFWLRXJPRRCJTI-UHFFFAOYSA-N iso-glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CCC(C)(C)O2)C2=C1 CFWLRXJPRRCJTI-UHFFFAOYSA-N 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- FHIREUBIEIPPMC-SADZTDHOSA-N k-Strophanthin-beta Chemical compound C1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C=O)CC[C@@H](C[C@@]5(O)CC[C@H]4[C@@]3(O)CC2)O[C@H]2C[C@@H]([C@@H]([C@@H](C)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)OC)=CC(=O)OC1 FHIREUBIEIPPMC-SADZTDHOSA-N 0.000 description 1
- -1 lactone Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 108010022457 polysaccharide peptide Proteins 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K63/00—Receptacles for live fish, e.g. aquaria; Terraria
- A01K63/003—Aquaria; Terraria
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K63/00—Receptacles for live fish, e.g. aquaria; Terraria
- A01K63/04—Arrangements for treating water specially adapted to receptacles for live fish
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
- Y02A40/818—Alternative feeds for fish, e.g. in aquacultures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种河蟹的生态养殖方法,包括以下步骤:1)池塘建立;2)蟹苗选择;3)水质处理;4)放苗;5)加水换水处理;6)投饵管理。本发明在投饵管理中,针对蟹的生长特点在第一阶段间断性加入中药添加剂,一方面可以防止螃蟹一开始无法适应但是又可以通过中药添加剂杀虫抗菌,另外,在第一阶段和第二阶段的中药添加剂不仅可以抗细菌、抗病毒还可以增强免疫功能,从而防止幼蟹时期各种疾病,提高存活率;在第二阶段和第三阶段采用与第一阶段和第二阶段不同的中药添加剂,一方面是根据螃蟹的生长阶段防止病菌和抗真菌,另外一方面添加中药成分改善螃蟹的水质和增加鲜度。
Description
【技术领域】
本发明涉及一种养殖方法,尤指一种河蟹的生态养殖方法。
【背景技术】
蟹肉中含有多种维生素,其中维生素A高于其他陆生及水生动物,维生素B2是肉类的5-6倍,比鱼类高出6-10倍,比蛋类高出2-3倍。维生素B1及磷的含量比一般鱼类高出6-10倍。每100克大闸蟹可食部分含蛋白质17.5,脂肪2.8克,磷182毫克,钙126毫克,铁2.8毫克。蟹壳除含有丰富的钙外,还含有蟹红素、蟹黄素等,因此,河蟹被大量的养殖。
目前,养殖河蟹的常规方法包括以下步骤:1)选择蟹苗;2)池塘水质处理;3)放苗;4)投饵管理:直接投放动物性,如螺肉、鱼肉等饵料;上述方法在每一个阶段都是投放动物性饵料,虽然动物饵料能加快螃蟹的生长,但是会产生很多寄生虫和细菌,致使螃蟹成活率低,品质下降。
【发明内容】
鉴于以上问题,本发明提供一种河蟹的生态养殖方法,该养殖方法在不同阶段投放不同的饵料,并且饵料中含有抗细菌、抗病毒及增强免疫功能的中药成分,从而提高蟹的存活率及品质。
为达到上述目的,本发明采用如下技术方案:一种河蟹的生态养殖方法,所述河蟹的生态养殖方法包括有以下步骤:
1)池塘建立:分为育苗池和养殖池;其中,
育苗池:选择水源充足,进排水方便,水质良好无污染,通气性好的地方,面积为0.5~1亩,坡度比为0.5:1~2,池内挖深0.3~0.4m、宽1~2m的蟹沟,四周建立高为50~60cm的防逃墙,材料使用塑料膜;池中浅水区水位为30~40cm,深水区水位在60~70cm;进水口和排水口均设置成直径为10~15cm圆孔,且均安装有50~70目的滤网;池塘内按照水草覆盖率为50~60%栽种有苦草、水花生、红蛋,并且投放有总高度为5~10cm小石头,小石头直径为2~8cm,另外,每亩放入5~8公斤的泥炭土;
养殖池:位于育苗池一侧,面积为2~3亩,坡度为1:2~2.5,池内挖深1~1.5m、宽4~5m的蟹沟,四周建立高度为60~70cm的防逃墙,材料使用塑料膜;养殖池中的浅水区水位为60~70cm,深水区水位在100cm~120cm;进水口和排水口均设置有直径为12~17cm的圆孔,且均安装有80~100目的滤网;池塘内以轮叶黑藻、水葫芦、绿毛藻、绿菊花为主,每亩用草量为13-16kg,行间距为0.8-1m,并且投放有总高度为8~12cm石头,石头直径为5~9cm,另外,每亩放入10~20公斤的泥炭土;
2)蟹苗选择:体重在50~80g之间,且规格一致、体色一致、活动能力强的蟹苗;
3)水质处理:育苗池,在放蟹苗前12~15天,每亩用100~120公斤的中药混合粉I泼洒消毒,且保持水温在18~25℃,其中,中药混合粉I由如下重量份的原料一起粉碎而成:芦荟粉1~2份、丝瓜2~3份、预知子0.2~0.4份、板蓝根1~2份、石榴皮0.1~0.3份;
养殖池:每隔10~15天,取如下原料粉碎得到的中药混合粉II:合欢木皮1~2份、板蓝根1~2份、白杨树0.1~0.3份、苦竹叶0.2~0.4份、罗布麻叶0.1~0.3份,然后按照每亩洒放120~140公斤的中药混合粉II进行消毒,且保持水温在20~25℃;
4)放苗:放苗前先用高锰酸钾10~15g/m3溶液浸泡2~3分钟,再放入清水中8~10分钟,重复2~3次,而后将消毒后的蟹苗按照10~20只/次放入育苗池中,待所有蟹苗慢慢散开后,再接着将余下的蟹苗按照上述方式放入育苗池中;
5)加水换水处理:育苗池,每隔10天换水一次以保持浅水区的水质透明度在20cm以上,深水区的水质透明度在50cm以上;夏天2~3天加水一次以保持浅水区的平均水位在35cm,深水区的平均水位在65cm;
养殖池:每隔5-8天换水一次以保持浅水区的水质透明度在50cm以上,深水区的水质透明度在80cm以上;夏天2~3天加水一次以保持浅水区的平均水位在65cm,深水区的平均水位在110cm;
6)投饵管理:
a)第一阶段:从放入育苗池后1~10天,每日采用饵料I进行两次喂养,每次每只按照蟹重量的2~3%喂养,饵料I包括有以下百分比的成分:螺肉75%、黄豆淀粉20%及山芋粉5%,并且每隔3~5天饵料I中加入中药添加剂I,其中,中药添加剂I由如下重量份的原料组成:大蒜0.1~0.3份、仙鹤草0.2~0.4份、苦参0.2~0.4份、芭蕉花0.05~0.07份、大枣0.02~0.04份、当归0.02~0.04份、中边莲0.01~0.03份、鱼腥草0.2~0.4份;
b)第二阶段:从放入育苗池后11~20天,每日采用饵料II进行三次喂养,每次每只按照蟹重量的2.5~3.5%喂养,饵料II包括有以下百分比的成分:玉米淀粉85%、鱼粉10%及中药添加剂I 5%;
c)第三阶段:从育苗池转入养殖池后5个月内,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,所述饵料III包括有以下百分比的成分:豆粕20%、螺肉65%、鱼粉5%及蚕蛹10%,并且每隔3~5天饵料III中加入中药添加剂II,其中,中药添加剂II由如下重量份的原料组成:杜仲叶0.2~0.4份、南瓜子0.2~0.4份、野菊花0.01~0.03份、蒲公英0.01~0.03份、大黄0.2~0.4份、大青叶0.02~0.04份、甘草0.3~0.6份、槐花0.05~0.07份;
d)第四阶段:从育苗池转入养殖池5个月后,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,饵料III包括以下成分:鸡肉80%、鸡蛋壳粉5%、肉骨粉5%、维生素4%及中药添加剂II 6%。
本发明具有以下有益效果:
本发明在投饵管理中,针对蟹的生长特点在第一阶段间断性加入中药添加剂,一方面可以防止螃蟹一开始无法适应但是又可以通过中药添加剂杀虫抗菌,另外,在第一阶段和第二阶段的中药添加剂不仅可以抗细菌、抗病毒还可以增强免疫功能,从而防止幼蟹时期各种疾病,提高存活率;在第二阶段和第三阶段采用与第一阶段和第二阶段不同的中药添加剂,一方面是根据螃蟹的生长阶段防止病菌和抗真菌,另外一方面添加中药成分改善螃蟹的水质和增加鲜度。
本发明中的中药原料详细情况如下:
芦荟的功效和作用:1.增强体质健康的人,服用芦荟和坚持芦荟浴,不仅可以防治各种疾病,而且还能改善体质,增强体力,保持精力旺盛。健康人体液呈弱碱性,过度劳累或生活紧张等原因会使体液变成酸性,易感染病毒,常用库拉索芦荟会使体液保持碱性,维持健康、不患感冒。2.杀菌芦荟酊是抗菌性很强的物质,能杀灭多种真菌、霉菌、细菌、病毒等病菌,抑制和消灭病原体的发育繁殖。3.抗炎芦荟的缓激肽酶与血管紧张来联合可抵抗炎症。尤其是芦荟的多糖类可增强人体对疾病的抵抗力,治愈皮肤炎、慢性肾炎、膀胱炎、支气管炎等慢性病症。4.湿润美容芦荟多糖和维生素对人体的皮肤有良好的营养、滋润、增白作用。尤其是青春少女最烦恼的粉刺,芦荟对消除粉刺有很好的效果。芦荟大黄素等属蒽醌甙物质,这类物质能使头发柔软而有光泽、轻松舒爽,且具有去头屑的作用。因此,芦荟美容霜、芦荟护肤霜、芦荟染发膏等芦荟化妆品占了欧洲化妆品市场的80%。5.健胃下泄芦荟中的芦荟大黄素甙、芦荟大黄素等有效成分起着增进食欲、大肠缓泄作用。服用芦荟,能强化胃功能,增强体质,体质衰弱而失去食欲的病危患者,服用芦荟也能恢复食欲。芦荟是古今中外治疗便秘最有效的药物,即使非常严重的便秘,服用芦荟之后,也能在8-12小时内通便,是因为芦荟素成分增加大肠液的分泌,增加脂肪酶的活性,恢复失调的大肠自律神经功能的缘故,并且,不会有任何副作用或药物依赖性。6.强心活血芦荟中的异柠檬酸钙等具有强心、促进血液循环、软化硬化动脉、降低胆固醇含量、扩张毛细血管的作用,使血液循环畅通,减少胆固醇值,减轻心脏负担,使血压保持正常,清除血液中的“毒素”。7.促进伤口愈合芦荟素A、创伤激素和聚糖肽甘露(Ke-2)等具有抗病毒感染,促进伤口愈合复原的作用,有消炎杀菌、吸热消肿、软化皮肤、保持细胞活力的功能,凝胶多糖与愈伤酸联合还具有愈合创伤活性,因此,它是一种治疗外伤(出血性外伤、不出血性外伤)不留伤痕的理想药品。8.免疫与抗肿瘤芦荟中的粘稠物质多糖类具有提高免疫力和抑制、破坏异常细胞的生长的作用,从而达到抗癌目的。9.解毒作用芦荟本身无毒无害无副作用,不会产生抗体。芦荟中的aloetin alomicin等成分具有分解生物体内有害物质的作用,还能消除生物体外部侵入的毒素。放射线或核放射能治疗癌症过程中会引起的烧伤性皮肤溃疡,有芦荟治疗不仅有解毒、消炎、再生新细胞的作用,还能增加因放射治疗而减少的白血球。10.抗衰老作用芦荟中的粘液(mucin,就是蛋白质),是以arboran A Baloe mannanaloetin等多糖类为核心成分,粘液类物质是防止细胞老化和治疗慢性过敏的重要成分。粘液素存在于人体的肌肉和胃肠粘膜等处,让组织富有弹性,如果液素不足,肌肉和粘膜就会丧失了弹性而僵硬老化。构成人体的细胞,如果粘液素不足,细胞就会逐渐衰弱,失去防御病菌、病毒的能力。另外,粘液素还有壮身、强精作用。11.镇痛、镇静作用手指肿痛、牙痛而难以忍受时,在患部贴上芦荟生叶,能消除疼痛,神经痛、痛风、筋肉痛等,内服加外用芦荟,也有镇痛效果。芦荟还能预防和治疗宿醉、晕车、晕船等。12.防晒作用芦荟中的天然蒽醌甙或蒽的衍生物,能吸收紫外线,防止皮肤红、褐斑产生。13.防虫、防腐作用芦荟汁液具有很好的消毒、防腐作用。夏天皮肤上涂上芦荟汁,蚊子不咬。哥伦比亚人常给小孩脚上抹上芦荟汁,以防止虫害。芦荟汁喷洒门窗和室内,苍蝇不入,傣族人就是用芦荟汁防止苍蝇进室内的。14.防臭作用芦荟具有防止脚、口、腋等体臭的作用。很早以前,人们就用芦荟来消除体臭。
丝瓜,性味,甘,平;主治,痘疮不快,枯者烧存性,入朱砂研末,蜜水调服,甚妙(震亨)。煮食,除热利肠。老者烧存性服,去风化痰,凉血解毒,杀虫,通经络,行血脉,下乳汁,治大小便下血,痔漏崩中,黄积,疝痛卵肿,血气作痛,痈疽疮肿,齿,痘疹胎毒(时珍)。暖胃补阳,固气和胎。
预知子,性味,苦,寒;主治,杀虫疗蛊,治诸毒。去皮研服,有效(《开宝》)。治一切风,补五劳七伤,其功不可备述。治癖气块,消宿食,止烦闷,利小便,催生,中恶失音,发落,天行温疾,涂一切蛇虫蚕咬,治一切病,每日吞二、七粒,不过三千粒,永瘥(大明)。
板蓝根,性味归经,苦,大寒。入心、胃经;与靛青叶同,能入肝胃血分,不过清热、解毒、辟疫、杀虫四者而已。
石榴皮,性味,酸、涩、温;功能,涩汤:用于久泻、久痢。(2)杀虫:用于杀绦虫及蛔虫。
合欢木皮,性味,甘,平;主治,安五脏,和心志,令人欢乐无忧。久服,轻身明目,得所欲(《本经》)。煎膏,消痈肿,续筋骨(大明)。杀虫。捣末,和铛下墨,生油调,涂蜘蛛咬疮器)折伤疼痛,花研末,酒服二钱匕。
白杨树,性味,涩微苦,凉;功能主治,清热解毒,消炎,利水,杀虫。治肾炎,感冒,蛔虫症,牙痛。
苦竹叶,性味,苦,冷;功效,口疮目痛,明目利九窍(《别录》)。治不睡,止消渴,解酒毒,除烦热,发汗,疗中风喑哑(大明)。杀虫。烧末,和猪胆,涂小儿头疮耳疮疥癣;和鸡子白,涂一切恶疮,频用取效(时珍)。
罗布麻叶,药理作用:1、降压作用罗布麻叶煎剂对肾型高血压狗灌胃后2小时,血压从194/142mm汞柱降至152/100mm汞柱,并一直稳定在较低水平,3天后才有回升。2、强心作用罗布麻根中所含加拿大麻甙对离体及在位猫心均能使其收缩幅度增大,心率变慢,然后心律不齐,终于心跳停止于收缩期,其作用性质和速度与毒毛旋花子甙相似,戊巴比妥钠等中枢抑制药能减弱它的强心作用。用罗布麻根提取物对在位猫心进行实验,亦表现强心甙样作用。同属植物(如加拿大麻Apocynum cannabium)用于心房纤维颤动的患者,效力较洋地黄差,如用至足以控制心律紊乱的剂量,往往引起恶心、呕吐、腹泻。3、对实验性心脏疾病的影响加拿大麻甙对犬实验性心血管机能不足,有治疗作用,家兔心肌炎之急性循环障碍的症状有所减轻,并能防止心肌及冠状血管硬化,此作用较毒毛旋花子甙为优。它能使动脉粥样硬化家兔的心电图变化恢复正常,而对冠脉的收缩作用尤为显着,对垂体后叶素及凝血酶所致的家兔冠脉循环机能不足之动脉粥样硬化亦有疗效,但较弱。能增加心脏糖元再合成。[用,而对高脂饲料喂饲的小鼠高血脂症无效;说明罗布麻叶对内源性血脂升高有降低作用。4、抗辐射损害罗布麻叶浸膏2g/kg灌胃,0.5g/kg腹腔注射,连续15-20天,可延长60Coγ-射线照射小鼠的生存天数,增加存活率,使血液白细胞数增加,槲皮素30mg/kg灌胃也有同样作用,认为罗布麻叶抗辐射作用与槲皮素有关。5、对脾脏的作用三十烷醇对正常幼鼠的生长无明显影响;对小鼠脾脏有增重作用,肌肉注射20mg/kg尤为显着;对鼠胸腺影响不一致,成年鼠胸腺略有增重,幼鼠则略减重;对环磷酰胺引起的脾脏、胸腺减重有明显对抗作用;对小鼠腹腔巨噬细胞吞噬功能有增强作用。6、对心血管系统的作用罗布麻浸膏水滤液(10%)给麻醉狗静脉恒速注射(2.0ml/kg、3.6ml/min),血压下降。7分钟以上)下降最大达22.3%,血压下降同时伴有心率减慢(r=0.83),心率减慢自给药后持续30分钟。血压降低同时心输出量、心脏指数、心搏指数及冠状动脉左回旋支血流量减少。对心脏前后负荷无影响。静脉注射3分钟内心肌耗氧量减少。给犬静脉注射罗布麻叶煎剂(0.25g/kg)或其黄酮甙(10-15mg/kg),1-10分钟后,心率明显减慢,30分钟后恢复,当煎剂剂量增至1g/kg,黄酮甙增至20mg/kg时,可出现心率失常,ST段压低,T波变形,说明两者均可引起心脏毒性反应。犬、猫静脉注射罗布麻叶黄酮甙5-15mg/kg,亦可使血压平均下降12.6-36.7%;一次给药降压作用维持3-10分钟,但有快速耐受性,给实验性肾型高血压犬灌胃罗布麻叶煎剂(1.5.10g/kg),出现5g/kg可出现血压下降。给药2小时后可以从194/142降至152/100mmHg,三日后才回升。黄酮甙每次5mg灌流离体兔耳血管时具有明显扩张血管作用。7、利尿作用罗布麻叶水浸膏及浸膏的烧残渣有利尿作用,大鼠口服罗布麻叶水浸膏后6-24小时及24小时总尿量分别增加50.60%及32.28%,与此同时尿钠及尿钾排出量也相应增加,但给药组与对照组之间尿钾及尿钠浓度无显着差异。家免静脉注射罗布麻叶水浸膏30分钟后,尿量明显增加(尿量增加在28.96-106.20%之间),作用持续2小时以上,而尿钠及尿钾排出量未见有明显增加(尿钾排出量仅在2小时内有增加现象),尿钠及尿钾浓度均低于给药前水平。犬静脉注射罗布麻叶水浸膏后60分钟内的各时相尿量明显增加,尿钠、尿钾的排出量也相应增加,但尿钠及尿钾的浓度均低于供药前水平。罗布麻叶浸膏灼烧残渣对家兔有快速而强烈的利尿作用,但作用持续时间较浸膏剂为短。8、降血脂作用罗布麻叶水浸膏能显着降低Triton造成高脂血症大鼠的血清总胆固醇值、三酸甘油酯值,但未能降低小鼠因高脂饲料形成高胆固醇血症的胆固醇值。9、延缓衰老作用罗布麻叶提取物对果蝇、家蚕、小鼠有延缓衰老或延长寿命作用。罗布麻叶浸膏对小鼠内脏脂褐质含量有不同程度的降低作用,并可使不同年龄组小鼠的肝脏和心脏的超氧化物歧化酶(SOD)活力普遍上升。罗布麻茶可提高红细胞内SOD值以及HDL-e,对防止动脉硬化可能有益。化学成分:叶中含有槲皮素(quercetin),异槲皮甙(iso-quercitrin),金丝桃甙(hyperoside),芸香甙(rutin),右旋儿茶精(catechin),恩醌(anthraquinone),谷氨酸(glutamic acid),丙氨酸(alanine),缬氨酸(valine)等多种氨基酸,二十九烷(nona-cosane),三十烷醇(1-triacontanol),三十一烷(hentriacontane),羽扇豆醇棕榈酸酯(lupenyl palmitate),棕榈酸蜂花醇酯(myricylpamitate),棕榈酸十六醇酯(hexadecyl palmitate),内消旋肌醇(meso-inositol),β-谷甾醇(β-sitosterol),氯化钾,鞣质及多糖,羽扇豆醇(lupeol),异秦皮定(isofraxidin)和东莨菪素(scopoletin)等。根含加拿大麻甙(cymarin),K-毒毛旋花子次甙-β(K-stro-phanthin-β)及毒毛旋花子甙元(strophanthidin)。
大蒜,性味,味辛,温;功用主治,解毒杀虫,消肿止痛,止泻止痢,治肺,驱虫,此外还有温脾暖胃。治痈疽肿毒,白秃癣疮,痢疾泄泻,肺痨顿咳,蛔虫蛲虫,饮食积滞,脘腹冷痛,水肿胀满。
仙鹤草,性味归经,苦、凉。归胃、肝、脾、肺、大肠经;功能主治,功效与作用:1.止血。促进血液凝固。2.强心。调整心率,大量服用能使心搏徐缓。3.抗菌。体外试验能抑制革兰氏阳性菌。4.驱虫。其根芽有驱绦虫作用。
苦参,苦,寒。有清热燥湿,杀虫,利尿之功。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风,外治滴虫性阴道炎。
芭蕉花,性味,味甘淡、微辛,性凉;功能,具有化痰软坚,平肝,和瘀,通经的功效;主治,主治胸膈饱胀,脘腹痞疼,吞酸反胃,呕吐痰涎,头目昏眩,心痛怔忡,妇女经行不畅。
当归,性味,甘、辛、温;归经,归肝、心、脾经;功能主治,补血;活血;调经止痛;润燥滑肠。主血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。
杜仲叶,性味甘、微辛;性温。入肝经、肾经。主治腰脊酸疼,风湿痹痛,胎动不安,习惯性流产等;具补肝肾、强筋骨、降血压、安胎等诸多功效。适宜高血压患者、习惯性流产妇女、小儿麻痹后遗症患者、肾气不足;具有清除体内垃圾,加强人体细胞物质代谢,防止肌肉骨骼老化,平衡人体血压,分解体内胆固醇,降低体内脂肪,恢复血管弹性,利尿清热,广谱抗菌,兴奋中枢神经,提高白血球数量,增强人体免疫力等显著功效。
南瓜子,南瓜味甘、性温,入脾,胃经;具有补中益气,消炎止痛,解毒杀虫,降糖止渴的功效;主治久病气虚、脾胃虚弱、气短倦怠、便溏、糖尿病、蛔虫等病症。
蒲公英,性味,苦甘,寒;归经,入肝、胃经;功能主治,清热解毒,利尿散结。治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,尿路感染。
大黄,性味,苦,寒;归经,入胃、大肠、肝经;功能主治,泻热毒,破积滞,行瘀血。治实热便秘,谵语发托,食积痞满,痢疾初起,里急后重,瘀停经闭,癥瘕积聚,时行热疫,暴眼赤痛,吐血,衄血,阳黄,水肿,淋浊,溲亦,痈疡肿毒,疔疮,汤火伤。
大青叶,性味,味苦,性寒;归经,归肝,心,胃,脾经;功效,清热解毒,凉血消斑;主治,用于热病高热烦渴;神昏;斑疹;吐血;衄血;黄疸;泻痢;丹毒;喉痹;口疮;痄腮。
甘草,含有多种化学成分,主要成分有甘草酸、甘草甙等。甘草的化学组成极为复杂,目前为止从甘草中分离出的化合物有甘草甜素、甘草次酸、甘草甙、异甘草甙、新甘草甙、新异甘草甙、甘草素、异甘草素以及甘草西定、甘草醇、异甘草醇、7-甲基香豆精、伞形花内酯等数十种化合物,但这些成分和数量通常会随甘草的种类、种植区域、采收时间等因素的不同而异。大量的研究表明,甘草甜素和黄酮类物质是甘草中最重要的生理活性物质,主要存在于甘草根表皮以内的部分。
槐花,性味苦凉,无毒、归肝、大肠经,具有清热泻火、凉血止血的作用。主治肠风便血,痔血,血痢,尿血,血淋,崩漏,吐血,衄血,肝火头痛,目赤肿痛,喉痹,失音,痈疽疮疡。
【具体实施方式】
下面的实施例可以帮助本领域的技术人员更全面的理解本发明,但不可以以任何方式限制本发明。
实施例1:
一种河蟹的生态养殖方法,包括有以下步骤:
1)池塘建立:分为育苗池和养殖池;其中,
育苗池:选择水源充足,进排水方便,水质良好无污染,通气性好的地方,面积为0.5~1亩,坡度比为0.5:1~2,池内挖深0.3~0.4m、宽1~2m的蟹沟,四周建立高为50~60cm的防逃墙,材料使用塑料膜;池中浅水区水位为30~40cm,深水区水位在60~70cm;进水口和排水口均设置成直径为10~15cm圆孔,且均安装有50~70目的滤网;池塘内按照水草覆盖率为50~60%栽种有苦草、水花生、红蛋,并且投放有总高度为5~10cm小石头,小石头直径为2~8cm,另外,每亩放入5~8公斤的泥炭土;
养殖池:位于育苗池一侧,面积为2~3亩,坡度为1:2~2.5,池内挖深1~1.5m、宽4~5m的蟹沟,四周建立高度为60~70cm的防逃墙,材料使用塑料膜;养殖池中的浅水区水位为60~70cm,深水区水位在100cm~120cm;进水口和排水口均设置有直径为12~17cm的圆孔,且均安装有80~100目的滤网;池塘内以轮叶黑藻、水葫芦、绿毛藻、绿菊花为主,每亩用草量为13-16kg,行间距为0.8-1m,并且投放有总高度为8~12cm石头,石头直径为5~9cm,另外,每亩放入10~20公斤的泥炭土;
2)蟹苗选择:体重在50~80g之间,且规格一致、体色一致、活动能力强的蟹苗;
3)水质处理:
育苗池,在放蟹苗前12~15天,每亩用100~120公斤的中药混合粉I泼洒消毒,且保持水温在18~25℃,其中,中药混合粉I由如下重量份的原料一起粉碎而成:芦荟粉1~2份、丝瓜2~3份、预知子0.2~0.4份、板蓝根1~2份、石榴皮0.1~0.3份;
养殖池:每隔10~15天,取如下原料粉碎得到的中药混合粉II:合欢木皮1~2份、板蓝根1~2份、白杨树0.1~0.3份、苦竹叶0.2~0.4份、罗布麻叶0.1~0.3份,然后按照每亩洒放120~140公斤的中药混合粉II进行消毒,且保持水温在20~25℃;
4)放苗:放苗前先用高锰酸钾10~15g/m3溶液浸泡2~3分钟,再放入清水中8~10分钟,重复2~3次,而后将消毒后的蟹苗按照10~20只/次放入育苗池中,待所有蟹苗慢慢散开后,再接着将余下的蟹苗按照上述方式放入育苗池中;
5)加水换水处理:育苗池,每隔10天换水一次以保持浅水区的水质透明度在20cm以上,深水区的水质透明度在50cm以上;夏天2~3天加水一次以保持浅水区的平均水位在35cm,深水区的平均水位在65cm;
养殖池:每隔5-8天换水一次以保持浅水区的水质透明度在50cm以上,深水区的水质透明度在80cm以上;夏天2~3天加水一次以保持浅水区的平均水位在65cm,深水区的平均水位在110cm;
6)投饵管理:
a)第一阶段:从放入育苗池后1~10天,每日采用饵料I进行两次喂养,每次每只按照蟹重量的2~3%喂养,饵料I包括有以下百分比的成分:螺肉75%、黄豆淀粉20%及山芋粉5%,并且每隔3~5天饵料I中加入中药添加剂I,其中,中药添加剂I由如下重量份的原料组成:大蒜0.1份、仙鹤草0.2份、苦参0.2份、芭蕉花0.05份、大枣0.02份、当归0.02份、中边莲0.01份、鱼腥草0.2份;
b)第二阶段:从放入育苗池后11~20天,每日采用饵料II进行三次喂养,每次每只按照蟹重量的2.5~3.5%喂养,饵料II包括有以下百分比的成分:玉米淀粉85%、鱼粉10%及中药添加剂I 5%;
c)第三阶段:从育苗池转入养殖池后5个月内,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,所述饵料III包括有以下百分比的成分:豆粕20%、螺肉65%、鱼粉5%及蚕蛹10%,并且每隔3~5天饵料III中加入中药添加剂II,其中,中药添加剂II由如下重量份的原料组成:杜仲叶0.2份、南瓜子0.2份、野菊花0.01份、蒲公英0.01份、大黄0.2份、大青叶0.02份、甘草0.3份、槐花0.05份;
d)第四阶段:从育苗池转入养殖池5个月后,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,饵料III包括以下成分:鸡肉80%、鸡蛋壳粉5%、肉骨粉5%、维生素4%及中药添加剂II 6%。
实施例2
一种河蟹的生态养殖方法,包括有以下步骤:
1)池塘建立:分为育苗池和养殖池;其中,
育苗池:选择水源充足,进排水方便,水质良好无污染,通气性好的地方,面积为0.5~1亩,坡度比为0.5:1~2,池内挖深0.3~0.4m、宽1~2m的蟹沟,四周建立高为50~60cm的防逃墙,材料使用塑料膜;池中浅水区水位为30~40cm,深水区水位在60~70cm;进水口和排水口均设置成直径为10~15cm圆孔,且均安装有50~70目的滤网;池塘内按照水草覆盖率为50~60%栽种有苦草、水花生、红蛋,并且投放有总高度为5~10cm小石头,小石头直径为2~8cm,另外,每亩放入5~8公斤的泥炭土;
养殖池:位于育苗池一侧,面积为2~3亩,坡度为1:2~2.5,池内挖深1~1.5m、宽4~5m的蟹沟,四周建立高度为60~70cm的防逃墙,材料使用塑料膜;养殖池中的浅水区水位为60~70cm,深水区水位在100cm~120cm;进水口和排水口均设置有直径为12~17cm的圆孔,且均安装有80~100目的滤网;池塘内以轮叶黑藻、水葫芦、绿毛藻、绿菊花为主,每亩用草量为13-16kg,行间距为0.8-1m,并且投放有总高度为8~12cm石头,石头直径为5~9cm,另外,每亩放入10~20公斤的泥炭土;
2)蟹苗选择:体重在50~80g之间,且规格一致、体色一致、活动能力强的蟹苗;
3)水质处理:育苗池,在放蟹苗前12~15天,每亩用100~120公斤的中药混合粉I泼洒消毒,且保持水温在18~25℃,其中,中药混合粉I由如下重量份的原料一起粉碎而成:芦荟粉1~2份、丝瓜2~3份、预知子0.2~0.4份、板蓝根1~2份、石榴皮0.1~0.3份;
养殖池:每隔10~15天,取如下原料粉碎得到的中药混合粉II:合欢木皮1~2份、板蓝根1~2份、白杨树0.1~0.3份、苦竹叶0.2~0.4份、罗布麻叶0.1~0.3份,然后按照每亩洒放120~140公斤的中药混合粉II进行消毒,且保持水温在20~25℃;
4)放苗:放苗前先用高锰酸钾10~15g/m3溶液浸泡2~3分钟,再放入清水中8~10分钟,重复2~3次,而后将消毒后的蟹苗按照10~20只/次放入育苗池中,待所有蟹苗慢慢散开后,再接着将余下的蟹苗按照上述方式放入育苗池中;
5)加水换水处理:育苗池,每隔10天换水一次以保持浅水区的水质透明度在20cm以上,深水区的水质透明度在50cm以上;夏天2~3天加水一次以保持浅水区的平均水位在35cm,深水区的平均水位在65cm;
养殖池:每隔5-8天换水一次以保持浅水区的水质透明度在50cm以上,深水区的水质透明度在80cm以上;夏天2~3天加水一次以保持浅水区的平均水位在65cm,深水区的平均水位在110cm;
6)投饵管理:
a)第一阶段:从放入育苗池后1~10天,每日采用饵料I进行两次喂养,每次每只按照蟹重量的2~3%喂养,饵料I包括有以下百分比的成分:螺肉75%、黄豆淀粉20%及山芋粉5%,并且每隔3~5天饵料I中加入中药添加剂I,其中,中药添加剂I由如下重量份的原料组成:大蒜0.2份、仙鹤草0.3份、苦参0.3份、芭蕉花0.06份、大枣0.03份、当归0.03份、中边莲0.02份、鱼腥草0.3份;
b)第二阶段:从放入育苗池后11~20天,每日采用饵料II进行三次喂养,每次每只按照蟹重量的2.5~3.5%喂养,饵料II包括有以下百分比的成分:玉米淀粉85%、鱼粉10%及中药添加剂I 5%;
c)第三阶段:从育苗池转入养殖池后5个月内,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,所述饵料III包括有以下百分比的成分:豆粕20%、螺肉65%、鱼粉5%及蚕蛹10%,并且每隔3~5天饵料III中加入中药添加剂II,其中,中药添加剂II由如下重量份的原料组成:杜仲叶0.3份、南瓜子0.3份、野菊花0.02份、蒲公英0.02份、大黄0.3份、大青叶0.03份、甘草0.4份、槐花0.06份;
d)第四阶段:从育苗池转入养殖池5个月后,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,饵料III包括以下成分:鸡肉80%、鸡蛋壳粉5%、肉骨粉5%、维生素4%及中药添加剂II 6%。
实施例3
一种河蟹的生态养殖方法,包括有以下步骤:
1)池塘建立:分为育苗池和养殖池;其中,
育苗池:选择水源充足,进排水方便,水质良好无污染,通气性好的地方,面积为0.5~1亩,坡度比为0.5:1~2,池内挖深0.3~0.4m、宽1~2m的蟹沟,四周建立高为50~60cm的防逃墙,材料使用塑料膜;池中浅水区水位为30~40cm,深水区水位在60~70cm;进水口和排水口均设置成直径为10~15cm圆孔,且均安装有50~70目的滤网;池塘内按照水草覆盖率为50~60%栽种有苦草、水花生、红蛋,并且投放有总高度为5~10cm小石头,小石头直径为2~8cm,另外,每亩放入5~8公斤的泥炭土;
养殖池:位于育苗池一侧,面积为2~3亩,坡度为1:2~2.5,池内挖深1~1.5m、宽4~5m的蟹沟,四周建立高度为60~70cm的防逃墙,材料使用塑料膜;养殖池中的浅水区水位为60~70cm,深水区水位在100cm~120cm;进水口和排水口均设置有直径为12~17cm的圆孔,且均安装有80~100目的滤网;池塘内以轮叶黑藻、水葫芦、绿毛藻、绿菊花为主,每亩用草量为13-16kg,行间距为0.8-1m,并且投放有总高度为8~12cm石头,石头直径为5~9cm,另外,每亩放入10~20公斤的泥炭土;
2)蟹苗选择:体重在50~80g之间,且规格一致、体色一致、活动能力强的蟹苗;
3)水质处理:育苗池,在放蟹苗前12~15天,每亩用100~120公斤的中药混合粉I泼洒消毒,且保持水温在18~25℃,其中,中药混合粉I由如下重量份的原料一起粉碎而成:芦荟粉1~2份、丝瓜2~3份、预知子0.2~0.4份、板蓝根1~2份、石榴皮0.1~0.3份;
养殖池:每隔10~15天,取如下原料粉碎得到的中药混合粉II:合欢木皮1~2份、板蓝根1~2份、白杨树0.1~0.3份、苦竹叶0.2~0.4份、罗布麻叶0.1~0.3份,然后按照每亩洒放120~140公斤的中药混合粉II进行消毒,且保持水温在20~25℃;
4)放苗:放苗前先用高锰酸钾10~15g/m3溶液浸泡2~3分钟,再放入清水中8~10分钟,重复2~3次,而后将消毒后的蟹苗按照10~20只/次放入育苗池中,待所有蟹苗慢慢散开后,再接着将余下的蟹苗按照上述方式放入育苗池中;
5)加水换水处理:育苗池,每隔10天换水一次以保持浅水区的水质透明度在20cm以上,深水区的水质透明度在50cm以上;夏天2~3天加水一次以保持浅水区的平均水位在35cm,深水区的平均水位在65cm;
养殖池:每隔5-8天换水一次以保持浅水区的水质透明度在50cm以上,深水区的水质透明度在80cm以上;夏天2~3天加水一次以保持浅水区的平均水位在65cm,深水区的平均水位在110cm;
6)投饵管理:
a)第一阶段:从放入育苗池后1~10天,每日采用饵料I进行两次喂养,每次每只按照蟹重量的2~3%喂养,饵料I包括有以下百分比的成分:螺肉75%、黄豆淀粉20%及山芋粉5%,并且每隔3~5天饵料I中加入中药添加剂I,其中,中药添加剂I由如下重量份的原料组成:大蒜0.3份、仙鹤草0.4份、苦参0.4份、芭蕉花0.07份、大枣0.04份、当归0.04份、中边莲0.03份、鱼腥草0.4份;
b)第二阶段:从放入育苗池后11~20天,每日采用饵料II进行三次喂养,每次每只按照蟹重量的2.5~3.5%喂养,饵料II包括有以下百分比的成分:玉米淀粉85%、鱼粉10%及中药添加剂I 5%;
c)第三阶段:从育苗池转入养殖池后5个月内,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,所述饵料III包括有以下百分比的成分:豆粕20%、螺肉65%、鱼粉5%及蚕蛹10%,并且每隔3~5天饵料III中加入中药添加剂II,其中,中药添加剂II由如下重量份的原料组成:杜仲叶0.4份、南瓜子0.4份、野菊花0.03份、蒲公英0.03份、大黄0.4份、大青叶0.04份、甘草0.6份、槐花0.07份;
d)第四阶段:从育苗池转入养殖池5个月后,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,饵料III包括以下成分:鸡肉80%、鸡蛋壳粉5%、肉骨粉5%、维生素4%及中药添加剂II 6%。
为说明本发明的效果,使用如下方法进行对比实验:
发明组:使用本发明实施例2;
对照组1:使用本发明实施例2,但是除了步骤6)中第一阶段和第二阶段未使用中药添加剂;
对照组2:使用本发明实施例2,但是除了步骤6)中第三阶段和第四阶段未使用中药添加剂;
对照组3:使用本发明实施例2,但是除了步骤6)中第一阶段至第四阶段均未使用中药添加剂。
采用发明组、对照组1~3分别养殖500只河蟹十个月,观察对比结果,见表1:
表1十个月后观察结果
组别 | 成活率 |
发明组 | 93.1% |
对照组1 | 80.2% |
对照组2 | 81.3% |
对照组3 | 70.1% |
从上述可见,本发明在投饵管理中,针对蟹的生长特点在第一阶段间断性加入中药添加剂,一方面可以防止螃蟹一开始无法适应但是又可以通过中药添加剂杀虫抗菌,另外,在第一阶段和第二阶段的中药添加剂不仅可以抗细菌、抗病毒还可以增强免疫功能,从而防止幼蟹时期各种疾病,提高存活率;在第二阶段和第三阶段采用与第一阶段和第二阶段不同的中药添加剂,一方面是根据螃蟹的生长阶段防止病菌和抗真菌,另外一方面添加中药成分改善螃蟹的水质和增加鲜度。
Claims (7)
1.一种河蟹的生态养殖方法,其特征在于:所述河蟹的生态养殖方法包括有以下步骤:
1)池塘建立:分为育苗池和养殖池;其中,
育苗池:选择水源充足,进排水方便,水质良好无污染,通气性好的地方,面积为0.5~1亩,坡度比为0.5:1~2,池内挖深0.3~0.4m、宽1~2m的蟹沟,四周建立高为50~60cm的防逃墙,材料使用塑料膜;池中浅水区水位为30~40cm,深水区水位在60~70cm;进水口和排水口均设置成直径为10~15cm圆孔,且均安装有50~70目的滤网;池塘内按照水草覆盖率为50~60%栽种有苦草、水花生、红蛋,并且投放有总高度为5~10cm小石头,小石头直径为2~8cm,另外,每亩放入5~8公斤的泥炭土;
养殖池:位于育苗池一侧,面积为2~3亩,坡度为1:2~2.5,池内挖深1~1.5m、宽4~5m的蟹沟,四周建立高度为60~70cm的防逃墙,材料使用塑料膜;养殖池中的浅水区水位为60~70cm,深水区水位在100cm~120cm;进水口和排水口均设置有直径为12~17cm的圆孔,且均安装有80~100目的滤网;池塘内以轮叶黑藻、水葫芦、绿毛藻、绿菊花为主,每亩用草量为13-16kg,行间距为0.8-1m,并且投放有总高度为8~12cm石头,石头直径为5~9cm,另外,每亩放入10~20公斤的泥炭土;
2)蟹苗选择:体重在50~80g之间,且规格一致、体色一致、活动能力强的蟹苗;
3)水质处理:育苗池,在放蟹苗前12~15天,每亩用100~120公斤的中药混合粉I泼洒消毒,且保持水温在18~25℃,其中,中药混合粉I由如下重量份的原料一起粉碎而成:芦荟粉1~2份、丝瓜2~3份、预知子0.2~0.4份、板蓝根1~2份、石榴皮0.1~0.3份;
养殖池:每隔10~15天,取如下原料粉碎得到的中药混合粉II:合欢木皮1~2份、板蓝根1~2份、白杨树0.1~0.3份、苦竹叶0.2~0.4份、罗布麻叶0.1~0.3份,然后按照每亩洒放120~140公斤的中药混合粉II进行消毒,且保持水温在20~25℃;
4)放苗:放苗前先用高锰酸钾10~15g/m3溶液浸泡2~3分钟,再放入清水中8~10分钟,重复2~3次,而后将消毒后的蟹苗按照10~20只/次放入育苗池中,待所有蟹苗慢慢散开后,再接着将余下的蟹苗按照上述方式放入育苗池中;
5)加水换水处理:育苗池,每隔10天换水一次以保持浅水区的水质透明度在20cm以上,深水区的水质透明度在50cm以上;夏天2~3天加水一次以保持浅水区的平均水位在35cm,深水区的平均水位在65cm;
养殖池:每隔5-8天换水一次以保持浅水区的水质透明度在50cm以上,深水区的水质透明度在80cm以上;夏天2~3天加水一次以保持浅水区的平均水位在65cm,深水区的平均水位在110cm;
6)投饵管理:
a)第一阶段:从放入育苗池后1~10天,每日采用饵料I进行两次喂养,每次每只按照蟹重量的2~3%喂养,饵料I包括有以下百分比的成分:螺肉75%、黄豆淀粉20%及山芋粉5%,并且每隔3~5天饵料I中加入中药添加剂I,其中,中药添加剂I由如下重量份的原料组成:大蒜0.1~0.3份、仙鹤草0.2~0.4份、苦参0.2~0.4份、芭蕉花0.05~0.07份、大枣0.02~0.04份、当归0.02~0.04份、中边莲0.01~0.03份、鱼腥草0.2~0.4份;
b)第二阶段:从放入育苗池后11~20天,每日采用饵料II进行三次喂养,每次每只按照蟹重量的2.5~3.5%喂养,饵料II包括有以下百分比的成分:玉米淀粉85%、鱼粉10%及中药添加剂I 5%;
c)第三阶段:从育苗池转入养殖池后5个月内,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,所述饵料III包括有以下百分比的成分:豆粕20%、螺肉65%、鱼粉5%及蚕蛹10%,并且每隔3~5天饵料III中加入中药添加剂II,其中,中药添加剂II由如下重量份的原料组成:杜仲叶0.2~0.4份、南瓜子0.2~0.4份、野菊花0.01~0.03份、蒲公英0.01~0.03份、大黄0.2~0.4份、大青叶0.02~0.04份、甘草0.3~0.6份、槐花0.05~0.07份;
d)第四阶段:从育苗池转入养殖池5个月后,每日采用饵料III进行三次喂养,每次每只按照蟹重量的3~4%喂养,饵料III包括以下成分:鸡肉80%、鸡蛋壳粉5%、肉骨粉5%、维生素4%及中药添加剂II 6%。
2.如权利要求1所述的一种河蟹的生态养殖方法,其特征在于:所述中药混合粉I由如下重量份的原料组成:芦荟粉1.5份、丝瓜2.5份、预知子0.3份、板蓝根1.5份、石榴皮0.2份。
3.如权利要求2所述的一种河蟹的生态养殖方法,其特征在于:所述中药混合粉II由如下重量份的原料组成:合欢木皮1.5份、板蓝根1.5份、白杨树0.2份、苦竹叶0.3份、罗布麻叶0.2份。
4.如权利要求3所述的一种河蟹的生态养殖方法,其特征在于:在步骤4)中,高锰酸钾浓度为2~5%。
5.如权利要求4所述的一种河蟹的生态养殖方法,其特征在于:在步骤4)中,每亩放1000~1200/只蟹苗。
6.如权利要求4所述的一种河蟹的生态养殖方法,其特征在于:所述中药添加剂I由如下重量份的原料组成:大蒜0.2份、仙鹤草0.3份、苦参0.3份、芭蕉花0.06份、大枣0.03份、当归0.03份、中边莲0.02份、鱼腥草0.3份。
7.如权利要求6所述的一种河蟹的生态养殖方法,其特征在于:所述中药添加剂II由如下重量份的原料组成:杜仲叶0.3份、南瓜子0.3份、野菊花0.02份、蒲公英0.02份、大黄0.3份、大青叶0.03份、甘草0.4份、槐花0.06份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610645173.8A CN106259079A (zh) | 2016-08-08 | 2016-08-08 | 一种河蟹的生态养殖方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610645173.8A CN106259079A (zh) | 2016-08-08 | 2016-08-08 | 一种河蟹的生态养殖方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106259079A true CN106259079A (zh) | 2017-01-04 |
Family
ID=57666925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610645173.8A Pending CN106259079A (zh) | 2016-08-08 | 2016-08-08 | 一种河蟹的生态养殖方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106259079A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106888998A (zh) * | 2017-02-28 | 2017-06-27 | 铜仁市凯盛水产养殖有限公司 | 一种大闸蟹的防病害方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060076632A (ko) * | 2004-12-29 | 2006-07-04 | 명노환 | 참게 양식용 인공어초 |
CN102715106A (zh) * | 2012-05-21 | 2012-10-10 | 高雷 | 一种罗氏沼虾虾苗的培育方法 |
CN103314902A (zh) * | 2013-06-17 | 2013-09-25 | 苏州市阳澄湖现代农业发展有限公司 | 一种河蟹无公害池塘高效养殖方法 |
CN103371114A (zh) * | 2012-04-23 | 2013-10-30 | 新沂市佳成生态养殖有限公司 | 一种河蟹的养殖方法 |
CN105248331A (zh) * | 2015-10-31 | 2016-01-20 | 佛山市高明区杨和镇金峰水产养殖场 | 一种高效养殖罗氏沼虾的方法 |
CN105475188A (zh) * | 2015-11-30 | 2016-04-13 | 苏州市相城区太平蟹业专业合作社 | 一种可提高螃蟹成活率的螃蟹养殖方法 |
-
2016
- 2016-08-08 CN CN201610645173.8A patent/CN106259079A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060076632A (ko) * | 2004-12-29 | 2006-07-04 | 명노환 | 참게 양식용 인공어초 |
CN103371114A (zh) * | 2012-04-23 | 2013-10-30 | 新沂市佳成生态养殖有限公司 | 一种河蟹的养殖方法 |
CN102715106A (zh) * | 2012-05-21 | 2012-10-10 | 高雷 | 一种罗氏沼虾虾苗的培育方法 |
CN103314902A (zh) * | 2013-06-17 | 2013-09-25 | 苏州市阳澄湖现代农业发展有限公司 | 一种河蟹无公害池塘高效养殖方法 |
CN105248331A (zh) * | 2015-10-31 | 2016-01-20 | 佛山市高明区杨和镇金峰水产养殖场 | 一种高效养殖罗氏沼虾的方法 |
CN105475188A (zh) * | 2015-11-30 | 2016-04-13 | 苏州市相城区太平蟹业专业合作社 | 一种可提高螃蟹成活率的螃蟹养殖方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106888998A (zh) * | 2017-02-28 | 2017-06-27 | 铜仁市凯盛水产养殖有限公司 | 一种大闸蟹的防病害方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106212338A (zh) | 一种河虾的环保养殖方法 | |
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN106259071A (zh) | 一种河蟹的天然养殖方法 | |
CN106035861A (zh) | 一种具有保健功能的桦褐孔菌代用茶及其制备方法 | |
CN102784363A (zh) | 一种治疗胰腺癌的中药组合物及其制备方法 | |
CN103520655B (zh) | 一种治疗寻常型银屑病的中药组合物及其制备方法 | |
CN104815192A (zh) | 一种治疗高血压的药物组合物及其应用 | |
CN106362125A (zh) | 一种保健足贴及其使用方法 | |
CN105853878A (zh) | 一种强身益寿中药组合物及其制备方法 | |
CN102886014A (zh) | 一种清血消炎的抗肿瘤药物 | |
CN104489172A (zh) | 一种提高免疫力的刺五加保健茶及其制备方法 | |
CN104522213A (zh) | 适宜三高人群饮用的茶饮及其制备方法 | |
KR20180089696A (ko) | 천연식물 추출물의 잔류농약 제거방법 | |
CN105343593A (zh) | 一种降压降脂的夏枯草保健口服液及其制备方法 | |
KR20160147424A (ko) | 와송 추출물이 포함된 효소조성물 | |
CN104432052A (zh) | 一种能抗疲劳防衰老的保健胶囊及其制备方法 | |
CN106259079A (zh) | 一种河蟹的生态养殖方法 | |
CN106259077A (zh) | 一种河虾的生态养殖方法 | |
CN103099885A (zh) | 具有祛痤疮功能软胶囊及其制备方法 | |
CN106259076A (zh) | 一种河蟹的养殖方法 | |
CN101897733A (zh) | 一种治疗膀胱结石的药物及其制备方法 | |
CN105031324A (zh) | 一种中药眼药水及其制备方法 | |
CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 | |
KR20180121435A (ko) | 원적외선 증류수가 포함되는 발효 흑한방약재 제조방법 | |
CN106434176A (zh) | 具有降三高功能的保健酒及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170104 |